Use of critically endangered medicinal plants to be phased out

20 plant species have been declared as being ‘unsustainably exploited’ by Karnataka Biodiversity Board

January 25, 2015 01:39 pm | Updated 01:39 pm IST - Bengaluru:

Ashoka tree

Ashoka tree

In a few months, numerous “sought-after” ayurvedic medicines will be taken off the shelves as Karnataka Biodiversity Board (KBB) is phasing out the use of critically endangered medicinal plant species.

Of the 425 plant species obtained from pharmaceutical companies, the board has reviewed 40 species that were put on the red list — that is, endangered or vulnerable species — of the International Union for Conservation of Nature (IUCN).

And of the 40 species, 20 have been declared as being “unsustainably exploited”. The board has suggested phasing them out in a timeframe ranging from six months to two years. This is part of implementing the National Biodiversity Board guidelines issued on November 21 last year on access-benefit sharing between local bodies and pharmaceutical companies.

For instance, the use of the popular Ashoka tree, which is classified by the IUCN as “vulnerable”, has been recommended for being phased out within six months. Nearly 15,337 tonnes of its bark, taken primarily from the Western Ghats, is used annually by pharma companies in the State.

“We have estimated that the demand is around 10,500 tonnes. At this level of demand, the entire supply may be wiped out. Even now, companies are struggling to meet the demand by adulterating Ashoka barks with the barks of seven other trees,” said M. Sanjappa, former Director of Botanical Survey of India and a KBB member.

Similarly, the use of Salacia genus of plants, including Salacia oblonga , Salacia chinensis (Saptrangi), and others used for treatment of diabetes, has to be phased out within six months.

“We will also recommend that companies be encouraged to take up cultivation of these species, instead of using them from the wild,” said Mr. Sanjappa.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.